[LABD] Direxion Daily S&P Biotech Bear 3X ETF

Overview

Type of security: Fund

Tags: Biotech, Equity, Health care, Inverse, Inverse 3X

The data is delayed by 15 minutes.

 

Price: 16.89 Change: -1.99 (-10.54%)
Ext. hours: 16.88 Change: -0.01 (-0.06%)

chart LABD

Refresh chart

Strongest Trends Summary For LABD

LABD is in the medium-term down -39% in 7 months. In the long-term down -94% in 5 years.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart

 

See how to gain 20% in 14 sec with TrendsInvesting

Technical Data
High 52 week58.86 Low 52 week16.49 Last close22.96 Last change3.66%
RSI58.86 Average true range1.94 Beta-4.57 Volume4.08 M
Simple moving average 20 days5.73% Simple moving average 50 days14.87% Simple moving average 200 days-16.31%
Performance Data
Performance Week3.8% Performance Month4.65% Performance Quart2.36% Performance Half-42.58%
Performance Year-18.14% Performance Year-to-date-46.17% Volatility daily5.19% Volatility weekly11.61%
Volatility monthly23.78% Volatility yearly82.39% Relative Volume215.56% Average Volume4.79 M
New High New Low
Funds Characteristics
30-day SEC yield Average market capitalization Average weighted market capitalization Forward P/E
Gross expense ratio Index dividend yield Median market cap Number of holdings
Price to Book Value Price to Earnings Total expense ratio Total net assets
Weighted market capitalization

News

2019-06-04 10:43:52 | Day Trading With Leveraged ETFs

2019-05-23 10:10:02 | 5 Leveraged/Inverse ETFs That Are Up 20% Plus So Far in Q2

2019-04-09 14:26:00 | In the Age of Algorithms

2019-04-09 09:25:24 | Big Moves In Leveraged Biotech ETFs

2019-01-14 10:05:37 | This Biotech ETF Is Soaring, But A Bearish Friend Lures Traders

2018-12-21 10:58:03 | 7 Inverse ETFs That Soared More Than 70% in Q4

2018-11-13 15:57:45 | The Time Could Be Right For This Biotech ETF

2018-10-09 11:59:03 | 7 Leveraged/Inverse ETFs Off to a Strong Start in October

2018-08-31 09:12:41 | How the Biotech Sector Has Fared this Year

2018-07-18 12:27:43 | Exploring The Leveraged ETF Trade Heading Into Earnings Season

2018-03-28 11:43:17 | For Now, Traders Endorse Biotech Rally

2018-02-28 16:30:00 | Direxion Announces Reverse Splits of Five ETFs

2017-11-29 16:46:23 | Short Interest And Leveraged ETFs

2017-11-15 13:18:00 | How venture philanthropy is helping to find a diabetes cure

2017-11-14 15:49:03 | Latest Tax Reform Bill From Senate GOP Seeks Repeal Of ACA Individual Mandate

2017-11-14 14:13:00 | GE made a mistake slashing its dividend, and the entire Dow is paying the price today: NYSE trader

2017-11-14 10:33:00 | Yellen, Draghi, Carney and Kuroda met in Frankfurt today—here's what went down

2017-11-13 13:45:00 | The biggest market-mover this week is the 'argy bargy' on taxes down in the Beltway: NYSE trader

2017-11-10 11:05:00 | Nvidia and Intel are set to be long-term market leaders

2017-11-10 10:55:00 | Stocks have bigger problems than tax reform

2017-11-09 17:20:00 | 3 signs the bulls are still kicking

2017-11-06 11:10:00 | Why the Broadcom bid for Qualcomm may end in a proxy battle

2017-08-31 16:37:34 | A Sign Of Things To Come? Traders Are Betting On More Biotech Mergers

2017-07-27 14:43:02 | 4 Things To Know Before Trading A Leveraged ETF

2017-07-13 11:00:00 | This Market Action Is Once Again Sluggish

2017-06-30 11:38:00 | Fourth of July Fireworks May Be at Hand, but Today's Action Is a Dud

2017-06-28 10:45:00 | The Market Is Going Green, Yet Again

2017-02-17 13:40:00 | Biotech 2017: 4 Ideas for A Stockpicker's Year

2017-01-11 15:14:51 | What pharma investors ought to do after Donald Trump fires a salvo

2017-01-02 01:00:00 | NVDA, LABD, TWM: Rev Shark's Views

2016-12-28 11:24:00 | Dip Buying Wanes at Year's End

2016-12-08 10:34:26 | How Will Trump’s Take on the ACA Affect Healthcare Stocks?

2016-11-08 09:34:54 | Which Sectors to Invest in If Donald Trump Wins

2016-10-17 10:10:02 | ETFs to Play as Biotech Juggles Election & Earnings

2016-10-14 15:26:44 | Can Biotech Stocks Stay “Trendy”?

2016-09-29 14:00:00 | LABD Rallies as Mylan, Biotechs Slump LABD

2016-09-27 15:21:50 | Loving LABU: A Leveraged Biotech ETF On A Torrid Pace

2016-09-06 10:43:03 | Technicals, Politics Clash for Biotech ETFs

2016-08-25 14:14:58 | Clinton Mylan Attack Reminds Biotech ETF Investors of Election Risks

2016-08-25 06:52:48 | The Active Traders Guide To Hillary Clinton's Rhetoric

2016-08-04 13:46:57 | Biotech Rally Stokes Activity In Leveraged ETFs

2016-06-22 14:07:45 | Traders Get It Right Sort Of With Leveraged Biotech ETFs

2016-06-09 10:06:02 | Will New SEC Rules Hurt Triple Leveraged ETFs?

2016-06-07 00:33:52 | Biotech Bounce: Sizzle Or Fizzle?

2016-06-03 12:05:00 | How to Play the Biotech Rally IBB,GILD,LABD

2016-06-01 08:30:23 | Finally A Biotech ETF Bounce?

2016-05-16 08:00:35 | Resisting the Temptation of Biotech ETFs

2016-04-01 09:59:01 | Are These ETFs Making You An April Fool?

2016-02-29 13:45:00 | Top 10 ETFs Of 2016 To Date

2016-02-12 08:11:04 | This Little Nugget Of An ETF Is Delivering Astounding Returns

LABD motifs

There is no motif for this symbol